Hypertension Trial, Recruiting NCT06828692 Sponsor: China National Center for Cardiovascular Diseases Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06828692
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 35 and 79 years old
  • People who regularly attend a clinic for high blood pressure treatment and do not plan to travel during the study period
  • People who have been diagnosed with high blood pressure, with a systolic (top number) blood pressure reading of 140 mmHg or higher at the screening appointment
  • People who are currently taking either no blood pressure medications, or exactly two types of blood pressure medications from specific medication groups (confirm with trial site for details on which medication groups apply)
  • People who are willing to take part and able to sign a written consent form

Who may not be able to join:

  • People whose high blood pressure is thought to be caused by another medical condition, such as kidney disease, hormonal disorders, thyroid problems, or certain other underlying causes
  • People with a systolic (top number) blood pressure of 180 mmHg or higher, or a diastolic (bottom number) blood pressure of 110 mmHg or higher at the screening visit
  • People whose high blood pressure is suspected to only occur in a medical setting (sometimes called "white coat hypertension")
  • People with a history of coronary heart disease
  • People with a history of heart failure
  • People who cannot tolerate two or more types of blood pressure medications from specific medication groups (confirm with trial site for details)
  • People currently taking blood pressure medications outside of the specific groups allowed in this trial (confirm with trial site for details)
  • People with diagnosed chronic kidney disease, significantly reduced kidney function, or who are currently on dialysis
  • People with serious medical conditions such as cancer or liver problems
  • People currently experiencing an acute illness, including a new heart or stroke event within the past 3 months
  • People with difficulties with thinking, memory, or communication
  • People who are currently pregnant, breastfeeding, or planning to become pregnant or breastfeed during the study
  • People who are unwilling to take blood pressure medications or who have had difficulty following treatment plans in the past
  • People who are already taking part in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xin Zheng, Fuwai Hospital, China Academy of Medical Sciences, National Center for Cardiovascular Diseases

Phone: 0086 10 60686871

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
China National Center for Cardiovascular Diseases
Registry
ClinicalTrials.gov
Start date
26 May 2025
Est. completion
28 February 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

hierarchical composite outcome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov